Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Prostatic Neoplasms × Health Promotion × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Lung Neoplasms 4 Hematopoietic and Lymphatic System Neoplasm 3 Hematologic Neoplasms 3 Breast Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Obesity-Related Malignant Neoplasm 1 Neoplastic Syndromes, Hereditary 1 Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Motor Activity 1 Malignant Solid Neoplasm 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hodgkin Disease 1 Hematopoietic and Lymphoid System Neoplasm 1 HIV Infections 1 FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1 Colorectal Neoplasms, Hereditary Nonpolyposis 1 Colorectal Neoplasms 1 Breast Cancer, Familial 1 Bone Diseases, Metabolic 1 Anemia, Aplastic 1

Interventions

Radiosurgery 38 Magnetic Resonance Spectroscopy 33 Radiotherapy 25 Standard of Care 24 Exercise 24 Brachytherapy 19 Early Intervention, Educational 18 Magnetic Resonance Imaging 15 Surveys and Questionnaires 14 Androgen Antagonists 14 Interviews as Topic 13 Blood Specimen Collection 12 Multiparametric Magnetic Resonance Imaging 11 Methods 11 Biopsy 11 Specimen Handling 10 Radiotherapy, Intensity-Modulated 10 Psychiatric Rehabilitation 10 Prostatectomy 9 Educational Status 9 Therapeutics 8 Resistance Training 8 Radiation 7 Practice Guidelines as Topic 7 Diet Therapy 7 Acupuncture Therapy 7 gallium 68 PSMA-11 6 bicalutamide 6 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 6 Proton Therapy 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02871752 2023-03-13

REASSUREME

Northwestern University

Phase NA Completed

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡